Sign In
Buy MDGL
$513.43
+0.550 (+0.107%)
At Close: Jun 23, 2026
Gilead Sciences, Inc. (Nasdaq: GILD) announced the presentation of more than 40 abstracts reflecting the breadth of research from the company’s progra
Global Non-Alcoholic Steatohepatitis (NASH) Pipeline Review, H2 2020 - ResearchAndMarkets.com
12:00am, Monday, 24'th Aug 2020
The
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Major Shareholder Sells $786,094.92 in Stock
08:30am, Saturday, 22'nd Aug 2020
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) major shareholder Bay City Capital Llc sold 7,303 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The shares were s
Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2020
12:00pm, Friday, 21'st Aug 2020
New analyses of the interim analysis data from the Phase 3 REGENERATE study describe the benefit of obeticholic acid (OCA) on noninvasive measures of liver
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Founders’ story: Pleiogenix
01:30pm, Tuesday, 18'th Aug 2020
Pleiogenix is a biopharma startup developing treatments for liver diseases as well as Covid-19 and non-alcoholic steatohepatitis (NASH). It recently emerged as the winner of the INVEST Pitch Perfect
Viking Therapeutics: Another Year In Review
02:39pm, Thursday, 13'th Aug 2020
Recently announced Q2'20 financial results and provided key updates on development timelines. Filed IND for VK0214 in X-ALD.
CymaBay Therapeutics Inc. (CBAY) Q2 2020 Earnings Call Transcript | The Motley Fool
07:01am, Tuesday, 11'th Aug 2020
CBAY earnings call for the period ending June 30, 2020.
How Adam Smith Might Have Valued Amazon, Netflix, Tesla, And Tiny Biotechs (NASDAQ:AMZN)
04:23pm, Monday, 10'th Aug 2020
Adam Smith's invisible hand implies that the value a business provides to its customers is conjoined with the value of a business to its self-interested owners.
Inventiva S A : Descriptif du programme limité de rachat d'actions & reprise du contrat de liquidité | Zone bourse
03:54pm, Monday, 10'th Aug 2020Inventiva S A : DESCRIPTIF DU PROGRAMME LIMITE DE RACHAT D'ACTIONS & REPRISE DU CONTRAT DE LIQUIDITE | Zone bourse
03:45pm, Monday, 10'th Aug 2020
Terns Pharmaceuticals Appoints Senthil Sundaram as CEO, Mark Vignola, Ph.D., as CFO, and Erin Quirk, M.D., as President.
Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q2 2020 Results - Earnings Call Transcript
05:23pm, Sunday, 09'th Aug 2020
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Allen Baharaff - President and CEO Dr.
Alnylam Managing Through Covid-19 Challenges And Executing Well (NASDAQ:ALNY)
04:34pm, Friday, 07'th Aug 2020
COVID-19 drove a double-digit sequential decline in U.S. Onpattro revenue, but both Onpattro and Givlaari revenue exceeded expectations, with management lifting the lower end of its Onpattro revenue f
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jorgensen on Q2 2020 Results - Earnings Call Transcript
09:32am, Friday, 07'th Aug 2020
Novo Nordisk A/S (NYSE:NVO) Q2 2020 Earnings Conference Call August 6, 2020 07:00 ET Company Participants Lars Fruergaard Jorgensen - Chief Executive Officer Mads Krogsgaard Thomsen - EVP & Chief
